B. Belohradsky

发表

Home-based subcutaneous immunoglobulin G replacement therapy under real-life conditions in children and adults with antibody deficiency

B. Grimbacher, J. Thiel, F. Hoffmann, 2010, European journal of medical research.

Clinical and functional characterisation of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment

M. Herold, C. Dejaco, P. Lohse, 2007, Annals of the rheumatic diseases.

Immunoglobulin E in primary immunodeficiency diseases

B. Grimbacher, S. Holland, B. Belohradsky, 2002, Allergy.

Genetic linkage of hyper-IgE syndrome to chromosome 4.

A. Schäffer, S. Holland, H. Ochs, 1999, American journal of human genetics.

Evaluation of correlation between dose and clinical outcomes in subcutaneous immunoglobulin replacement therapy

J. Orange, B. Grimbacher, R. Wasserman, 2012, Clinical and experimental immunology.

Periodic fever due to a novel TNFRSF1A mutation in a heterozygous Chinese carrier of MEFV E148Q.

M. McDermott, P. Lohse, R. Mirakian, 2004, Rheumatology.

X-linked inhibitor of apoptosis (XIAP) deficiency: the spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis.

K. Schwarz, S. Ehl, H. von Bernuth, 2013, Clinical immunology.

Successful long-term correction of autosomal recessive hyper-IgE syndrome due to DOCK8 deficiency by hematopoietic stem cell transplantation.

U. Pannicke, K. Schwarz, U. Wintergerst, 2010, Klinische Padiatrie.

The German national registry for primary immunodeficiencies (PID)

C. Klein, S. Ehl, R. Krüger, 2013, Clinical and experimental immunology.